BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28668389)

  • 1. Inducible liver-specific overexpression of gankyrin in zebrafish results in spontaneous intrahepatic cholangiocarcinoma and hepatocellular carcinoma formation.
    Huang SJ; Cheng CL; Chen JR; Gong HY; Liu W; Wu JL
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1052-1058. PubMed ID: 28668389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway.
    Zhao X; Fu J; Xu A; Yu L; Zhu J; Dai R; Su B; Luo T; Li N; Qin W; Wang B; Jiang J; Li S; Chen Y; Wang H
    Cell Death Dis; 2015 May; 6(5):e1751. PubMed ID: 25950481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of gankyrin induces liver steatosis in zebrafish (Danio rerio).
    Her GM; Hsu CC; Hong JR; Lai CY; Hsu MC; Pang HW; Chan SK; Pai WY
    Biochim Biophys Acta; 2011 Sep; 1811(9):536-48. PubMed ID: 21722753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.
    Sun W; Ding J; Wu K; Ning BF; Wen W; Sun HY; Han T; Huang L; Dong LW; Yang W; Deng X; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2011 Oct; 54(4):1259-72. PubMed ID: 21735473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma.
    Sakurai T; Yada N; Hagiwara S; Arizumi T; Minaga K; Kamata K; Takenaka M; Minami Y; Watanabe T; Nishida N; Kudo M
    Cancer Sci; 2017 Oct; 108(10):1996-2003. PubMed ID: 28777492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma.
    Umemura A; Itoh Y; Itoh K; Yamaguchi K; Nakajima T; Higashitsuji H; Onoue H; Fukumoto M; Okanoue T; Fujita J
    Hepatology; 2008 Feb; 47(2):493-502. PubMed ID: 18161051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.
    Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC
    Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic expression of tgfb1a induces hepatic inflammation, fibrosis and metastasis in zebrafish.
    Yan C; Yang Q; Gong Z
    Biochem Biophys Res Commun; 2019 Jan; 509(1):175-181. PubMed ID: 30581008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas.
    Higashitsuji H; Itoh K; Nagao T; Dawson S; Nonoguchi K; Kido T; Mayer RJ; Arii S; Fujita J
    Nat Med; 2000 Jan; 6(1):96-9. PubMed ID: 10613832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance.
    Fu XY; Wang HY; Tan L; Liu SQ; Cao HF; Wu MC
    World J Gastroenterol; 2002 Aug; 8(4):638-43. PubMed ID: 12174370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zebrafish as a disease model for studying human hepatocellular carcinoma.
    Lu JW; Ho YJ; Yang YJ; Liao HA; Ciou SC; Lin LI; Ou DL
    World J Gastroenterol; 2015 Nov; 21(42):12042-58. PubMed ID: 26576090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1β/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis.
    Su B; Luo T; Zhu J; Fu J; Zhao X; Chen L; Zhang H; Ren Y; Yu L; Yang X; Wu M; Feng G; Li S; Chen Y; Wang H
    Hepatology; 2015 Feb; 61(2):585-97. PubMed ID: 25294684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of human oncoprotein gankyrin in Zebrafish.
    Kim SY; Hur W; Choi JE; Kim D; Wang JS; Yoon HY; Piao LS; Yoon SK
    Exp Mol Med; 2009 Jan; 41(1):8-16. PubMed ID: 19287195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma.
    Yang C; Tan YX; Yang GZ; Zhang J; Pan YF; Liu C; Fu J; Chen Y; Ding ZW; Dong LW; Wang HY
    J Exp Med; 2016 May; 213(5):859-75. PubMed ID: 27091842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis.
    Xue TC; Zhang BH; Ye SL; Ren ZG
    Tumour Biol; 2015 Aug; 36(8):5891-9. PubMed ID: 25712376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer.
    Jiang Y; Iakova P; Jin J; Sullivan E; Sharin V; Hong IH; Anakk S; Mayor A; Darlington G; Finegold M; Moore D; Timchenko NA
    Hepatology; 2013 Mar; 57(3):1098-106. PubMed ID: 23172628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma.
    Liu R; Li Y; Tian L; Shi H; Wang J; Liang Y; Sun B; Wang S; Zhou M; Wu L; Nie J; Lin B; Tang S; Zhang Y; Wang G; Zhang C; Han J; Xu B; Liu L; Gong K; Zheng T
    Cancer Lett; 2019 Feb; 443():34-46. PubMed ID: 30503555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of endothelin 1 triggers hepatocarcinogenesis in zebrafish and promotes cell proliferation and migration through the AKT pathway.
    Lu JW; Liao CY; Yang WY; Lin YM; Jin SL; Wang HD; Yuh CH
    PLoS One; 2014; 9(1):e85318. PubMed ID: 24416389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance.
    Jing H; Zhang G; Meng L; Meng Q; Mo H; Tai Y
    Sci Rep; 2014 Jul; 4():5503. PubMed ID: 24999092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.